Synthesis of five nevirapine metabolites

…, LJ Nummy, MD Ridges, A Salvagno

Index: Grozinger, Karl G.; Byrne, Denis P.; Nummy, Laurence J.; Ridges, Michael D.; Salvagno, Annette Journal of Heterocyclic Chemistry, 2000 , vol. 37, # 2 p. 229 - 239

Full Text: HTML

Citation Number: 27

Abstract

Abstract Nevirapine (1) is a non-nucleoside reverse transcriptase inhibitor marketed for HIV treatment by Boehringer Ingelheim as Viramune® since 1996. In vitro studies of nevirapine biotransformation using human liver microsomes demonstrated the formation of five major metabolites. This paper describes the syntheses of these metabolites.